Guangdong Hybribio Biotech Co Ltd (300639)

Currency in CNY
6.34
-0.02(-0.31%)
Closed·
300639 Scorecard
Full Analysis
Management has been aggressively buying back shares
300639 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.276.40
52 wk Range
4.328.33
Key Statistics
Bid/Ask
6.34 / 6.31
Prev. Close
6.36
Open
6.37
Day's Range
6.27-6.4
52 wk Range
4.32-8.33
Volume
9.97M
Average Volume (3m)
10.61M
1-Year Change
39.39%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300639 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Guangdong Hybribio Biotech Co Ltd Company Profile

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. The company was founded in 2003 and is based in Chaozhou, China.

Employees
2205
Market
China

Compare 300639 to Peers and Sector

Metrics to compare
300639
Peers
Sector
Relationship
P/E Ratio
−6.0x−16.5x−0.5x
PEG Ratio
0.010.490.00
Price/Book
1.0x5.4x2.6x
Price / LTM Sales
5.2x12.7x3.2x
Upside (Analyst Target)
-2.7%42.7%
Fair Value Upside
Unlock−16.4%5.8%Unlock

Earnings

Latest Release
May 05, 2025
EPS / Forecast
-0.04 / --
Revenue / Forecast
134.06M / --
EPS Revisions
Last 90 days

300639 Income Statement

FAQ

What Stock Exchange Does Guangdong Hybribio Biotech Trade On?

Guangdong Hybribio Biotech is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Guangdong Hybribio Biotech?

The stock symbol for Guangdong Hybribio Biotech is "300639."

What Is the Guangdong Hybribio Biotech Market Cap?

As of today, Guangdong Hybribio Biotech market cap is 4.02B.

What Is Guangdong Hybribio Biotech's Earnings Per Share (TTM)?

The Guangdong Hybribio Biotech EPS (TTM) is -1.05.

When Is the Next Guangdong Hybribio Biotech Earnings Date?

Guangdong Hybribio Biotech will release its next earnings report on 25 Aug 2025.

From a Technical Analysis Perspective, Is 300639 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Guangdong Hybribio Biotech Stock Split?

Guangdong Hybribio Biotech has split 5 times.

How Many Employees Does Guangdong Hybribio Biotech Have?

Guangdong Hybribio Biotech has 2205 employees.

What is the current trading status of Guangdong Hybribio Biotech (300639)?

As of 23 Jul 2025, Guangdong Hybribio Biotech (300639) is trading at a price of 6.34, with a previous close of 6.36. The stock has fluctuated within a day range of 6.27 to 6.40, while its 52-week range spans from 4.32 to 8.33.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.